researchers at the University of Texas (UT) Dell Medical School at Austin will use brain scans to study reactions after treatment with psilocybin and 5-MeO-DMT for combatants suffering from post-traumatic stress disorder (PTSD), traumatic brain injuries and other related conditions.
The Mission Inside is one of many nonprofit organizations Providing access to psychedelic therapy for veterans Retreats outside of the United States for reasons consistent with the legal status of these substances in the country.
The founder of the NGO Dr Martin Polanco explained that the current need for more evidence to support the approval of these types of therapies prompted the organization’s participation in the university’s study. “We believe it’s important to scientifically document what we’ve seen anecdotally,” Polanco explained.
The one created in 2021 Center for Psychedelic Research and Therapy at UT is carried out by dr Greg Fonzo and Charles Nemeroffwith an emphasis on assessing which populations would benefit most from psychedelics-assisted therapy, how often it should be administered, and at what doses.
The center’s first study will assess the ongoing grief diagnosis that Dr. Fonzo describes as a “black hole of misery”.
The study is now recruiting Goldstar women with the aim of studying thirty participants. Half of them receive psilocybin, five take 5-MeO-DMT and the remaining 10 receive a placebo.
Mission Within will administer the compounds outside of the United States, and participants will be transported to Austin for functional magnetic resonance imaging (fMRI) scans to measure brain responses before and after taking medication in real time.
“We will examine so-called behavioral tasks that people will complete in the fMRI scanner, some of which are very unique to grief,” explained Dr. Fonzo, including viewing pictures of their deceased spouses or viewing certain grief. related words.
Blood…
[ad_2]
Source story